Respiratory

US-based biotechnology firm Luminex has launched a new NxTAG Respiratory Pathogen Panel (RUO) test, which enables laboratories to simultaneously detect 22 respiratory pathogens in a single closed tube system.

The assay accommodates higher throughput required to respond to seasonal changes in demand.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Luminex president Homi Shamir said: "Luminex introduced multiplexed respiratory panels to the clinical market in 2008 and our customers are anxiously awaiting a next-generation product that delivers expanded panel coverage and a simple closed tube workflow, combined with the throughput and quality of results established by the xTAG Respiratory Viral Panel.

"The new respiratory assay needs only a few minutes and no upstream reagent preparation, while extracted samples are added directly to pre-plated, lyophilised reagents."

"We are also pleased to report that we remain on track with our NxTAG clinical trials schedule which started in the first quarter of the year, and we expect the FDA submission to occur in the summer of 2015."

The new respiratory assay needs only a few minutes and no upstream reagent preparation, while extracted samples are added directly to pre-plated, lyophilised reagents.

See Also:

With the help of Luminex MAGPIX instrument, the tubes are then sealed to prepare for closed tube amplification and subsequent detection.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new tube strip design enables laboratories to manage variable sample demand as it helps in processing a single sample or up to 96 samples per run without wasting consumables or reagents.

Capable of incorporating NxTAG easily into any laboratory, the accompanying SYNCT Software offers a comprehensive approach to data analysis and reporting.

According to the company, clinical trials for NxTAG are currently being carried out in the US.

Image: NxTAG allows testing for 22 respiratory targets with a closed tube system and an easy three-step workflow. Photo: courtesy of Luminex Corporation.